Learning Experience Reverses Catecholaminergic Effects on Adaptive Behavior

Int J Neuropsychopharmacol. 2020 Mar 10;23(1):12-19. doi: 10.1093/ijnp/pyz058.

Abstract

Background: Catecholamines are important for cognitive control and the ability to adapt behavior (e.g., after response errors). A prominent drug that modulates the catecholaminergic system is methylphenidate. On the basis of theoretical consideration, we propose that the effects of methylphenidate on behavioral adaptation depend on prior learning experience.

Methods: In a double-blind, randomized, placebo-controlled crossover study design, we examined the effect of methylphenidate (0.25 mg/kg) on post error behavioral adaptation processes in a group of n = 43 healthy young adults. Behavioral adaptation processes were examined in a working memory, modulated response selection task. The focus of the analysis was on order effects within the crossover study design to evaluate effects of prior learning/task experience.

Results: The effect of methylphenidate/placebo on post-error behavioral adaptation processes reverses depending on prior task experience. When there was no prior experience with the task, methylphenidate increased post-error slowing and thus intensified behavioral adaptation processes. However, when there was prior task experience, (i.e., when the placebo session was conducted first in the crossover design), methylphenidate even decreased post-error slowing and behavioral adaptation. Effect sizes were large and the power of the observed effects was higher than 95%.

Conclusions: The data suggest that catecholaminergic effects on cognitive control functions vary as a function of prior learning/task experience. The data establish a close link between learning/task familiarization and catecholaminergic effects for executive functions, which has not yet been studied, to our knowledge, but is of considerable clinical relevance. Theoretical implications are discussed.

Keywords: behavioral adaptation; cognitive control; dopamine; error; methylphenidate; norepinephrine.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Psychological / drug effects*
  • Adult
  • Cross-Over Studies
  • Dopamine / physiology
  • Double-Blind Method
  • Executive Function / drug effects*
  • Female
  • Humans
  • Male
  • Memory, Short-Term / drug effects
  • Methylphenidate / pharmacology*
  • Neurotransmitter Uptake Inhibitors / pharmacology*
  • Norepinephrine / physiology
  • Practice, Psychological*
  • Psychomotor Performance / drug effects*
  • Recognition, Psychology*
  • Young Adult

Substances

  • Neurotransmitter Uptake Inhibitors
  • Methylphenidate
  • Dopamine
  • Norepinephrine